Intravitreal antimicrobials

Intraocular Drug Delivery

Volumn , Issue , 2006, Pages 85-96

  Meredith, Travis A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895921343     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Baum J, Peyman GA, Barza M. Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Surv Ophthalmol 1982; 26:204-206.
2. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113:1479-1496.
3. Mann I. The intraocular use of penicillin. Br J Ophthalmol 1946; 30:134-136.
4. Von Sallman L, Meyer K, DiGrandi J. Experimental study on penicillin treatment of ectogenous infection of vitreous. Arch Ophthalmol 1944; 32:179-189.
5. Leopold IH, Scheie HG. Studies with microcrystalline sulfathiazole. Arch Ophthalmol 1943; 29:811.
6. Leopold IH. Intravitreal penetration of penicillin and penicillin therapy of infections of the vitreous. Arch Ophthalmol 1945; 33:211-216.
7. Liang C, Peyman GA, Sonmez M, Molinari LC. Experimental prophylaxis of Staphylococcus aureus endophthalmitis after vitrectomy: the use of antibiotics in irrigating solution. Retina 1999; 19:223-229.
8. Barza M, Kane A, Baum J. Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Invest Ophthalmol Vis Sci 1983; 24:1602-1606.
9. Fisher JP, Civiletto SE, Forster RK. Toxicity, efficacy, and clearance of intravitreally injected cefazolin. Arch Ophthalmol 1982; 100:650-652.
10. Ficker LA, Meredith TA, Gardner SK, Wilson LA. Cefazolin levels after intravitreal injection: effects of inflammation and surgery. Invest Ophthalmol Vis Sci 1990; 31: 502-505.
11. Shockley RK, Jay WM, Friberg TR, Aziz AM, Rissing JP, Aziz MZ. Intravitreal ceftriaxone in a rabbit model. Arch Ophthalmol 1984; 102:1236-1238.
12. Jay WM, Aziz MZ, Rissing JP, Shockley RK. Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys. Arch Ophthalmol 1985; 103:121-123.
13. Pflugfelder SC, Hernandez E, Fleisler SJ, Alvarez J, Pflugfelder M, Forster RK. Intravitreal vancomycin. Arch Ophthalmol 1987; 105:831-837.
14. Aguilar HE, Meredith TA, El-Massry A, et al. Vancomycin levels after intravitreal injection. Retina 1995; 15:428-432.
15. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D’Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol 1999; 117:1058-1062.
16. Nelson P, Peyman GA, Bennett TO. BB-K8: a new aminoglycoside for intravitreal injection in bacterial endophthalmitis. Am J Ophthalmol 1974; 78:82-89.
17. Meredith TA, Mandell BA, Aguilar EA, El-Massry A, Sawant A, Gardner S. Amikacin levels after intravitreal injection: effects of inflammation and surgery. Invest Ophthalmol Vis Sci 1992;33/34:747.
18. Cobo LM, Forster RK. The clearance of intravitreal gentamicin. Am J Ophthalmol 1981; 92:59-62.
19. Ben-Nun J, Joyce DA, Cooper RL. Pharmacokinetics of intravitreal injection: assessment of a gentamicin model by ocular dialysis. Invest Ophthalmol Vis Sci 1989; 30:1055-1061.
20. Gardner S. Treatment of bacterial endophthalmitis III. Ocul Ther Manage 1991; 2:14-19.
21. Barza M. Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation. Scan J Infect Dis 1978; 14(suppl):151-19.
22. Martin DF, Ficker LA, Aguilar HA, Gardner SK, Wilson LA, Meredith TA. Vitreous cefazolin levels after intravenous injection: effects of inflammation, repeated antibiotic doses, and surgery. Arch Ophthalmol 1990; 108:411-414.
23. Barza M. Antibacterial agents in the treatment of ocular infections. Infect Clin N Am 1989; 3:533-551.
24. Maurice DM. Injection of drugs into the vitreous body. In: Leopold IJ, Burns RP, eds. Symposium on Ocular Therapy. New York: John Wiley, 1976:59-72.
25. Maurice DM, Mishima S. Ocular pharmacokinetics. In: Sears ML, ed. Pharmacology of the Eye. New York: Springer-Verlag, 1984:19-116.
26. Rowland M, Tozer TN. Clinical Pharmacokinetics. Lea and Febiger. Philadelphia, PA: Saunders, 1989.
27. Lim JI, Anderson CT, Hutchinson A, Buggage RR, Grossniklaus HE. The role of gravity in gentamicin-induced toxic effects in a rabbit model. Arch Ophthalmol 1994; 112: 1363-1367.
28. Friedrich S, Saville B, Cheng YL. Drug distribution in the vitreous humor of the human eye: the effects of aphakia and changes in retinal permeability and vitreous diffusivity. J Ocul Pharmacol Ther 1997; 13:445-459.
29. Tojo KJ, Ohtori A. Pharmacokinetic model of intravitreal drug injection. Math Biosci 1994; 123:59-75.
30. Barza M, Lynch E, Baum JL. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993; 111:121-125.
31. Doft BH, Weiskopf J, Nillson-Ehle I, Wingard L. Amphotericin clearance in vitrectomized versus non-vitrectomized eyes. Ophthalmology 1985; 92:1601-1605.
32. Barza, M. Animal models in evaluation of chemotherapy of ocular infections. In: Zak O, Sande MA, eds. Experimental Models in Antimicrobial Chemotherapy. London: Harcourt Brace Jovanovich, 1986:187-211.
33. Meredith TA, Lindsey DT, Edelhauser HF, Goldman AI. Electroretinographic studies following vitrectomy and intraocular silicone oil injection. Br J Ophthalmol 1985; 69:254-260.
34. Marmor MF. Retinal detachment from hyperosmotic intravitreal injection. Invest Ophthalmol Vis Sci 1979; 18:1237-1244.
35. Peyman GA, Vastine DW, Raichand M. Postoperative endophthalmitis: experimental aspects and their clinical application. Ophthalmology 1978; 85:374-385.
36. Zachary IG, Forster RK. Experimental intravitreal gentamicin. Am J Ophthalmol 1976; 82:604-711.
37. Talamo JH, D’Amico DJ, Hanninen LA. The influence of aphakia and vitrectomy on experimental retinal toxicity of aminoglucoside antibiotics. Am J Ophthalmol 1985; 100:840-847.
38. Conway BP, Campochiaro PA. Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin. Arch Ophthalmol 1986; 104:367-371.
39. Campochiaro PA, Conway BP. Aminoglycoside toxicity: a survey of retinal specialists. Arch Ophthalmol 1991; 109:946-950.
40. Conway BP, Tabatabay CA, Campochiaro PA, D’Amico DJ, Hanninen LA, Kenyon KR. Gentamicin toxicity in the primate retina. Arch Ophthalmol 1989; 107:107-112.
41. D’Amico DJ, Caspers-Velu L, Libert J, et al. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol 1985; 100:264-275.
42. Oum BS, D’Amico DJ, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside. An experimental study of combination and repetitive injections. Arch Ophthalmol 1989; 107:1055-1060.
43. Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol 1999; 117:1023-1027.
44. Gan IM, van Dissel JT, Beekhuis WH, Swart W, van Meurs JC. Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol 2001; 85:1289-1293.
45. Campochiaro PA, Green WR. Toxicity of intravitreal ceftazidime in primate retina. Arch Ophthalmol 1992; 110:1625-1629.
46. Meredith TA. Antimicrobial pharmacokinetics in endophthalmitis treatment; studies of ceftazidime. Trans Am Ophth Soc 1993; 91:653-699.
47. Campochiaro PA, Lin JI, Group AS. Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994; 112:48-53.
48. Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting evidence against amikacin. Br J Ophthalmol 2002; 86:359-360.
49. Mandell BA, Meredith TA, Aguilar E, El-Massry A, Sawant A, Gardner S. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am J Ophthalmol 1993; 115:770-774.
50. Stevens SX, Fouraker BD, Jensen HG. Intraocular safety of ciprofloxacin. Arch Ophthalmol 1991; 109:1737-1743.
51. Wiechens B, Grammer JB, Johannsen U, Pleyer U, Hedderich J, Duncker GI. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 1999; 213:120-128.
52. Pearson PA, Hainsworth DP, Ashton P. Clearance and distribution of ciprofloxacin following intravitreal injection. Retina 1993; 13:326-330.
53. Wiechens B, Neumann D, Grammer JB, Pleyer U, Hedderich J, Duncker GI. Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Int Ophthalmol 1998; 22:133-143.
54. Gupta SK, Velpandian T, Dhingra N, Jaiswal J. Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes. J Ocul Pharmacol Ther 2000; 16:511-518.
55. Gupta SK, Dhingra N, Velpandian T, Jaiswal J. Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes. Acta Ophthalmol Scand 2000; 78:448-450.